In a recent commentary authored by Schroders Capital's Mark Gibson, Senior Investment Director ILS, and Christoph Hummel, ...
From testing, Delphi-2Ms’ predictions matched or exceeded the accuracy of current models for most diseases. It also proved to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback